The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Nuclear medicine outlook: The road ahead, a glance back
February 2nd 2007Expanded coverage for PET drove demand for procedures in 2006, helping push unit sales, which also benefited from local pressures on providers to keep up with the competition. Demand for upgrading the installed base to PET/CT from dedicated PET could bolster sales in the near term, just as the popularity of the modality continues to rise.
CAD firm prepares virtual colonoscopy launch in U.S.
February 1st 2007Italian computer-aided detection and imaging device company iM3D is slated to begin selling its CADColon iM3D system in this country this quarter. The company, which introduced itself to the U.S. radiology community in 2005 under the moniker iMED Medical Imaging Lab, is already selling CADColon in Europe and is awaiting approval from the FDA for marketing in the U.S. It plans to sell the product directly to customers but is also exploring relationships with imaging vendors interested in building its CAD algorithm into their workstations, said Alessandro Zuccato, head of sales.
MR colonography proves effective but unpleasant
February 1st 2007Although MR colonography is proving to be an effective method of colorectal screening, patients are no more likely to accept it than optical colonoscopy. In addition, limited bowel prep protocols for CT colonography are proving comparable to full cathartic prep.
Novel tracer for prostate cancer improves sensitivity
January 9th 2007Researchers at Emory University have demonstrated the uptake of a new radiotracer known as FACBC in both primary and metastatic prostate cancer on initial staging, as well as in recurrent cancer within the prostate bed, lymph nodes, and bone. They reported their findings in the January issue of the Journal of Nuclear Medicine.
Report from RSNA: Software boosts accuracy, reduces reading time for bone scans
January 2nd 2007Software designed by researchers at the University of Chicago helps detect interval changes in successive nuclear medicine bone scans and can reduce interpretation time by up to 32%, according to research presented in an educational exhibit at the RSNA meeting.
Coronary CTA lacks certainty as ischemia indicator
December 14th 2006Plaque buildup in the coronary arteries seen on 16- and 64-slice CT angiography does not always mean blood flow to the heart is restricted, according to research conducted at the Leiden University Medical Center in the Netherlands.
Positive results strengthen case for CT colonography screening
December 1st 2006This fall brought good news for advocates of CT colonography. A study in the November issue of Radiology presented the latest results from the University of Wisconsin, and they were very good: in a population of 1110 patients, CT colonography demonstrated a positive predictive value of 93.8% for polyps 6 mm and larger, up from 58.5% in an earlier trial conducted at the same institution (Radiology 2006;241:417-425).
Numa debuts storage, connectivity tools
December 1st 2006Nuclear medicine specialist Numa showed at the 2006 RSNA meeting enhancements for NumaLink, a cross-vendor data translation product, and NumaStore, a gamma camera and PET/CT image management system. The products promise greater connectivity within the nuclear medicine department and between nuclear medicine and radiology. Among NumaLink’s enhancements are DICOM translation capabilities for proprietary PET data sets, including those generated using Siemens and GE PET systems. The NumaStore upgrade supports Siemens’ preclinical microPET and the Inveon Dedicated PET small-animal imaging systems.
GE enhances LightSpeed VCT at RSNA meeting
November 29th 2006Software upgrades introduced by GE Healthcare this week for the company's LightSpeed VCT scanner promise to cut patient x-ray dose for coronary CT angiography by 70% or more and double the area covered during dynamic angiography and perfusion.
Software boosts accuracy, reduces reading time for bone scans
November 29th 2006Software designed by researchers at the University of Chicago helps detect interval changes in successive nuclear medicine bone scans, and can reduce interpretation time by up to 32%, according to research presented in an educational exhibit at the RSNA meeting.